Salix Pharmaceuticals (SLXP +0.2%) says it's submitted a New Drug Application to the FDA for its HIV-induced diarrhea drug Crofelemer. The agency has 60 days to review the application and decide whether it will enter its review process. The drug developer is also researching alternative possible uses for the drug, including the treatment of irritable bowel syndrome.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Wed, 4:39PM)
at Investor's Business Daily (Feb 23, 2015)
at Benzinga.com (Feb 23, 2015)
at Investor's Business Daily (Feb 20, 2015)
at Investor's Business Daily (Feb 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs